| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gamida Cell Ltd. | GENERAL COUNSEL | Ordinary Shares | 855K | $1.33M | $1.55 | Jan 31, 2024 | Direct |
| Gamida Cell Ltd. | GENERAL COUNSEL | Employee Share Option (Right to Buy) | 126K | Feb 8, 2023 | Direct | ||
| CG Oncology, Inc. | General Counsel and Chief Compliance Officer | Stock Option (Right to Buy) | 47.8K | Oct 4, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. | Oct 4, 2024 | 1 | $0 | 4 | Oct 7, 2024 | General Counsel and Chief Compliance Officer |
| CGON | CG Oncology, Inc. | May 15, 2024 | 1 | $0 | 4 | May 16, 2024 | General Counsel and Chief Compliance Officer |
| CGON | CG Oncology, Inc. | May 13, 2024 | 0 | $0 | 3 | May 16, 2024 | General Counsel and Chief Compliance Officer Exhibit 24 - Power of Attorney. |
| GMDA | Gamida Cell Ltd. | Jan 31, 2024 | 1 | $0 | 4 | Feb 2, 2024 | GENERAL COUNSEL |
| GMDA | Gamida Cell Ltd. | Feb 8, 2023 | 2 | $0 | 4 | Feb 10, 2023 | General Counsel |
| GMDA | Gamida Cell Ltd. | Jan 28, 2022 | 2 | $0 | 4 | Feb 1, 2022 | General Counsel |
| GMDA | Gamida Cell Ltd. | Jan 1, 2022 | 0 | $0 | 3 | Jan 3, 2022 | General Counsel |